Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Your DevOps maturity journey – part 3

In order to be truly effective, DevOps relies on Continuous Delivery (CD), which, in turn, requires Continuous Integration (CI). The release of incremental software changes needs not only automated release mechanisms, but also testing, code quality, security and privacy controls, and validation steps. For organizations in a highly regulated environment such as healthcare, however, validation…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

In order to be truly effective, DevOps relies on Continuous Delivery (CD), which, in turn, requires Continuous Integration (CI). The release of incremental software changes needs not only automated release mechanisms, but also testing, code quality, security and privacy controls, and validation steps. For organizations in a highly regulated environment such as healthcare, however, validation must be taken a step further through the process of Continuous Validation (CV). This blog is more about true DevOps and where the rubber hits the road.

GalaxE can help you benchmark your current DevOps maturity and has provided a roadmap to reach your full potential. The first four tiers are:

Tier 0: Traditional Waterfall

Tier 1: Iterative Waterfall

Tier 2: Early Reviews, and 

Tier 3: Agile Team

Let’s take a look at the final four tiers:

Tier 4: Transition to Agile – As an organization transitions toward agile artifacts and practices, the day-to-day duties of personnel will change. Team members will incorporate more QA measures to test the performance of their software as it is being developed, such as a focus on “Defined as Ready” (DoR) and “Defined as Done” (DoD).

Tier 5: Agile Practices – The team completes the transition of any legacy artifacts and processes until they are all agile. The development team collaborates closely with business stakeholders to deliver frequent, usable versions of the product. Teams then use the knowledge they acquire to fix mistakes they’ve found and to build on the previous version.

Tier 6: CI/CV/CD (Continuous Integration/Continuous Validation/Continuous Development) – This is a proactive, test-driven approach that uses automation in build, test, and release mechanisms to ensure continuity and accuracy. Process tools such as test-driven development (TDD) and software mapping are used to create a series of specific test cases. Each step is integrated into the software, validated, and then used to develop the next iteration.

Tier 7: DevOps – DevOps emphasizes automation and monitoring during all steps of software development, from integration through validation and deployment. Through this approach, DevOps aims to create shorter development cycles, increase deployment frequency, and deliver more dependable releases to meet business objectives. This process allows for more frequent releases in order to “fail faster,” resulting in more dependable software.

What’s different about the GalaxE approach is the capabilities of our enablement tools GxMaps™, GxDash™, and GxQuality™, which are a natural progression from QA automation. Once integrated, these tools enhance redundancy, diversity, reliability, and fault tolerance at the highest of levels. Integrating these solutions into your business is essential for efficient adaptation to shifting markets, regulation, and customer demands. Without them, businesses risk being outpaced by the competition.

Learn more about GxMaps™ application dependency mapping software and how it can help you achieve DevOps environments at https://galaxe.com/gx-maps/.

Read more at galaxe.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512